Palbociclib (trade name: Ibrance) has been approved since November 2016 for the treatment of women with advanced hormone receptor-positive breast cancer who are not eligible for chemotherapy, radiotherapy or further surgery. ...
Mar 2, 2017
New research findings published in the Journal of Leukocyte Biology, suggest that synovial CD4+ T cells that produce IL-21 contribute to joint inflammation by activating synovial fibroblasts in rheumatoid arthritis patients. ...
Mar 2, 2017
The inauguration of a new United States president is heralded as a peaceful transition of power. However, when a new administration actually takes office, the fast change in healthcare policy direction and ideological political ...
Mar 2, 2017
